» Articles » PMID: 35950844

Detection of Plasmid-Mediated Resistance to Metronidazole in Clostridioides Difficile from River Water

Overview
Specialty Microbiology
Date 2022 Aug 11
PMID 35950844
Authors
Affiliations
Soon will be listed here.
Abstract

Clostridioides difficile is one of the most important human pathogens. The identification of its possible sources is important for the understanding of C. difficile infection (CDI) epidemiology. A total of 16 water samples from wastewater and surface water in South Moravia in the Czech Republic and 82 samples of fish and gulls were collected between May and July 2019. C. difficile isolates were cultured by direct plating and after enrichment on chromogenic media. Susceptibility testing to eight antimicrobials was performed by Etest. C. difficile isolates were characterized by ribotyping, multilocus sequence typing, multilocus tandem repeats analysis, and toxin gene detection. Samples from fish and gulls were C. difficile negative; a total of 15 C. difficile isolates from 8 out of 16 water samples were cultured (6 out of 14 surface water samples yielded 6 isolates, and 2 out of 2 wastewater samples yielded 9 isolates). Direct plating was culture positive in 6 out of 16 samples (12 isolates), and enrichment culture was positive in an additional 2 out of 16 samples (3 isolates). Twelve different ribotyping profiles and 14 sequence types of clades 1, 4, and 5 were identified. Five isolates did not carry genes for toxins, and eight isolates carried genes for toxins A and B; the remaining two isolates (RT078) carried the genes for toxins A, B, and binary. All C. difficile isolates were susceptible to amoxicillin, moxifloxacin, tetracycline, and vancomycin and resistant to ciprofloxacin. A high level of erythromycin resistance (>256 mg/L) was detected in eight isolates. Clindamycin resistance was found in 14 isolates, 6 of which showed a high level of resistance (>256 mg/L) and carried . Surprisingly, one isolate (RT010, ST15) showed resistance to metronidazole (12 mg/L) with the presence of the plasmid pCD-METRO. In conclusion, a diverse spectrum of C. difficile strains was found in wastewater and surface water. A recently discovered plasmid-bound resistance to metronidazole was detected in C. difficile from the surface water sample. The combination of direct plating and culture after enrichment was used in order to gain a spectrum of C. difficile ribotypes present in the water samples. Toxigenic C. difficile ribotypes detected in surface water and in wastewater treatment plants overlapped with those derived from patients with CDI and/or animals. Importantly, a recently discovered plasmid-mediated resistance to metronidazole, a drug used for the treatment of CDI, was detected in C. difficile from river water.

Citing Articles

Abundant geographical divergence of Clostridioides difficile infection in China: a prospective multicenter cross-sectional study.

Bai L, Xu T, Zhang W, Jiang Y, Gu W, Zhao W BMC Infect Dis. 2025; 25(1):185.

PMID: 39920584 PMC: 11806848. DOI: 10.1186/s12879-025-10552-y.


Gene Expression Dysregulation in Whole Blood of Patients with Infection.

Tsakiroglou M, Evans A, Doce-Carracedo A, Little M, Hornby R, Roberts P Int J Mol Sci. 2024; 25(23).

PMID: 39684365 PMC: 11641058. DOI: 10.3390/ijms252312653.


Distribution of ribotypes and sequence types across humans, animals and food in 13 European countries.

Rupnik M, Viprey V, Janezic S, Tkalec V, Davis G, Sente B Emerg Microbes Infect. 2024; 13(1):2427804.

PMID: 39535868 PMC: 11610360. DOI: 10.1080/22221751.2024.2427804.


Diversity of PCR ribotypes isolated from freshwater sediments depends on the isolation method.

Rupnik M, Fuks A, Janezic S Appl Environ Microbiol. 2024; 90(10):e0144224.

PMID: 39269162 PMC: 11497773. DOI: 10.1128/aem.01442-24.


Genetic determinants of resistance to antimicrobial therapeutics are rare in publicly available Clostridioides difficile genome sequences.

Kolte B, Nubel U J Antimicrob Chemother. 2024; 79(6):1320-1328.

PMID: 38598696 PMC: 11144481. DOI: 10.1093/jac/dkae101.


References
1.
Clancy C, Buehrle D, Vu M, Wagener M, Nguyen M . Impact of Revised Infectious Diseases Society of America and Society for Healthcare Epidemiology of America Clinical Practice Guidelines on the Treatment of Clostridium difficile Infections in the United States. Clin Infect Dis. 2020; 72(11):1944-1949. DOI: 10.1093/cid/ciaa484. View

2.
Lawson P, Citron D, Tyrrell K, Finegold S . Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O'Toole 1935) Prévot 1938. Anaerobe. 2016; 40:95-9. DOI: 10.1016/j.anaerobe.2016.06.008. View

3.
Kecerova Z, Cizek A, Nyc O, Krutova M . Clostridium difficile isolates derived from Czech horses are resistant to enrofloxacin; cluster to clades 1 and 5 and ribotype 033 predominates. Anaerobe. 2019; 56:17-21. DOI: 10.1016/j.anaerobe.2019.01.005. View

4.
Sedlacek J, Babek O, Novakova T . Sedimentary record and anthropogenic pollution of a complex, multiple source fed dam reservoirs: An example from the Nové Mlýny reservoir, Czech Republic. Sci Total Environ. 2016; 574:1456-1471. DOI: 10.1016/j.scitotenv.2016.08.127. View

5.
Moradigaravand D, Gouliouris T, Ludden C, Reuter S, Jamrozy D, Blane B . Genomic survey of Clostridium difficile reservoirs in the East of England implicates environmental contamination of wastewater treatment plants by clinical lineages. Microb Genom. 2018; 4(3). PMC: 5885014. DOI: 10.1099/mgen.0.000162. View